Global Compliance News

The FCC has approved expanded unlicensed use of the 6GHz band, opening the door for new high‑power geofenced variable power (GVP) devices. The ruling supports next‑generation Wi‑Fi performance, AR/VR applications, automation, and short‑range hotspots while protecting licensed services from interference.

The U.S. Department of Health and Human Services will launch a new study examining potential health effects of cellphone radiation, following the FDA’s removal of older web pages on the topic. The review aims to clarify scientific gaps amid evolving wireless technologies.

The FCC is creating a new device category that will supercharge Wi-Fi and unlock outdoor AR/VR applications. Geofenced variable power devices operate at higher power levels in the 6GHz band—overcoming current limitations and enabling next-generation wireless innovation.

Fitness trackers and wellness wearables just got regulatory relief. The FDA's new draft guidance exempts low-risk consumer wellness devices from medical device scrutiny—unless they claim to be "medical grade." Here's what changed and what triggers stricter reviews.

The FDA can't protect patients without knowing shortages are coming. While the EU implemented mandatory device shortage reporting in 2025, the U.S. still has no requirements—leaving pediatric patients especially vulnerable to supply chain disruptions.

The FCC just voided Verizon's 60-day handset unlocking requirement after discovering a fraud problem: stolen devices ending up on international black markets and facilitating criminal enterprises. The new rules align Verizon with industry standards.

In Davos, leading voices from industry and academia examined how quantum computing is reshaping global trust, emphasizing post‑quantum security challenges and the expanding fusion of AI, cybersecurity, and autonomous systems.

After years of regulatory complexity, the EU Commission offers medical device manufacturers a path forward: proposed changes limit AI Act requirements for devices, streamline risk classifications, and create efficiencies that could reduce costs and speed innovation.

Good news for phone users: the FCC's annual robocall report shows complaints plummeting as enforcement intensifies. With 906,622 complaints over five years—down from 1.35 million previously—the agency's crackdown on illegal calls is clearly working.

The FDA's medical device recall oversight is failing—and staffing shortages are to blame. GAO's December report shows nearly three-quarters of recalls exceeded termination targets during 2020-2024, with congressional recommendations for strategic staffing increases now on the table.